Digital Health and AI Chatbots to Promote Sexual and Reproductive Health Among LBQ+ Women of Color
Studies in Health Technology and Informatics · 2025
DOI: 10.3233/shti251365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Studies in Health Technology and Informatics, 2025. Verfasst von Megan Threats und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Michigan, School of Information, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Telemedicine, Artificial Intelligence, Reproductive Health, Sexual Health. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMHD NIH HHS.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
This study investigated the acceptability of using digital health, including telemedicine (e.g., video calls on a computer or smartphone), mHealth (a mobile app, text messaging, and social media messages), and artificial intelligence-enabled chatbots to communicate health information and facilitate access and uptake of sexual and reproductive healthcare among lesbian, bisexual, and queer (LBQ+) women of color (WOC) in the United States.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Michigan, School of Information, Ann Arbor, MI, USA.
Förderung
- NIMHD NIH HHS
Zitieren
APA
Threats, M., Sha, Y., & Gray, M. (2025). Digital Health and AI Chatbots to Promote Sexual and Reproductive Health Among LBQ+ Women of Color. Studies in Health Technology and Informatics. https://doi.org/10.3233/shti251365
Vancouver
Threats M, Sha Y, Gray M. Digital Health and AI Chatbots to Promote Sexual and Reproductive Health Among LBQ+ Women of Color. Studies in Health Technology and Informatics. 2025. doi:10.3233/shti251365
BibTeX
@article{Threats2025,
author = {Threats, Megan and Sha, Yongjie and Gray, Morgan},
title = {Digital Health and AI Chatbots to Promote Sexual and Reproductive Health Among LBQ+ Women of Color},
journal = {Studies in Health Technology and Informatics},
year = {2025},
doi = {10.3233/shti251365}
}
EUVIMED